These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 34503213)

  • 1. Therapeutic Potential of Targeting the SUMO Pathway in Cancer.
    Kukkula A; Ojala VK; Mendez LM; Sistonen L; Elenius K; Sundvall M
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ALS-Associated SOD1 Mutant SUMOylation and Aggregation by SENP and PIAS Family Proteins.
    Wada H; Suzuki D; Niikura T
    J Mol Neurosci; 2020 Dec; 70(12):2007-2014. PubMed ID: 32462635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.
    Chen S; Dong D; Xin W; Zhou H
    Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer.
    Wu W; Huang C
    Life Sci; 2023 Nov; 332():122085. PubMed ID: 37722589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Dual SENP1 and SENP2 Inhibitor.
    Brand M; Bommeli EB; Rütimann M; Lindenmann U; Riedl R
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.
    Lara-Ureña N; Jafari V; García-Domínguez M
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO: From Bench to Bedside.
    Chang HM; Yeh ETH
    Physiol Rev; 2020 Oct; 100(4):1599-1619. PubMed ID: 32666886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the development of SUMO specific protease (SENP) inhibitors.
    Kumar A; Zhang KY
    Comput Struct Biotechnol J; 2015; 13():204-11. PubMed ID: 25893082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression.
    Bawa-Khalfe T; Yeh ET
    Genes Cancer; 2010 Jul; 1(7):748-752. PubMed ID: 21152235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease.
    Mendler L; Braun T; Müller S
    Circ Res; 2016 Jan; 118(1):132-44. PubMed ID: 26837744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO1 modification of 0N4R-tau is regulated by PIASx, SENP1, SENP2, and TRIM11.
    Wada H; Maruyama T; Niikura T
    Biochem Biophys Rep; 2024 Sep; 39():101800. PubMed ID: 39286522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications.
    Long X; Zhao B; Lu W; Chen X; Yang X; Huang J; Zhang Y; An S; Qin Y; Xing Z; Shen Y; Wu H; Qi Y
    Front Physiol; 2020; 11():558220. PubMed ID: 33192553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SENP Proteases as Potential Targets for Cancer Therapy.
    Tokarz P; Woźniak K
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33923236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
    Abdel-Hafiz HA; Horwitz KB
    BMC Mol Biol; 2012 Mar; 13():10. PubMed ID: 22439847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.
    Cui W; Sun M; Galeva N; Williams TD; Azuma Y; Staudinger JL
    Drug Metab Dispos; 2015 Sep; 43(9):1316-25. PubMed ID: 26063058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.
    Zhang FL; Yang SY; Liao L; Zhang TM; Zhang YL; Hu SY; Deng L; Huang MY; Andriani L; Ma XY; Shao ZM; Li DQ
    Theranostics; 2023; 13(3):973-990. PubMed ID: 36793866
    [No Abstract]   [Full Text] [Related]  

  • 17. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
    Hua D; Wu X
    Eur J Med Chem; 2022 Apr; 233():114227. PubMed ID: 35247754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revised annotation and extended characterizations of components of the
    Lin YL; Chung CL; Huang PJ; Chen CH; Fang SC
    Plant Direct; 2020 Sep; 4(9):e00266. PubMed ID: 33015534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
    Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
    J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and regulation of ubiquitin-like SUMO system in heart.
    Wang Y; Liu Z; Bian X; Zhao C; Zhang X; Liu X; Wang N
    Front Cell Dev Biol; 2023; 11():1294717. PubMed ID: 38033852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.